VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Ocugen, Inc. (OCGN) Total Return Calculator with Dividends Reinvested

Ocugen, Inc.

Popular:

The total return for Ocugen, Inc. (OCGN) stock is +103.44% over the past 12 months. So far it's up 5.43% this year. The 5-year total return is -84.81%, meaning $10,000 invested in OCGN stock 5 years ago would be worth $1,519 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in OCGN 1 year ago, it would be worth $21,976 today — you'd have gained $11,976.

With Dividends Reinvested$21,976+119.76%

Price Only (No DRIP)$21,976+119.76%

Period2025-05-07 → 2026-05-06

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in OCGN

1Y$20,344+$10,344 (+103.4%)103.4% CAGR

3Y$20,265+$10,265 (+102.6%)26.5% CAGR

5Y$1,519-$8,481 (-84.8%)-31.4% CAGR

10Y$147-$9,853 (-98.5%)-34.4% CAGR

15Y$21-$9,979 (-99.8%)-33.8% CAGR

20Y$21-$9,979 (-99.8%)-26.6% CAGR

30Y$21-$9,979 (-99.8%)-18.6% CAGR

Ocugen, Inc. did not pay dividends during this period. Total return = price return.

Loading OCGN total return...

As of 2026-05-07

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	+5.43%	—	+5.43%	—	$10,543
1Y	+103.44%	103.44%	+103.44%	—	$20,344
3Y	+102.65%	26.55%	+102.65%	—	$20,265
5Y	-84.81%	-31.40%	-84.81%	—	$1,519
10Y	-98.53%	-34.45%	-98.53%	—	$147
15Y	-99.79%	-33.78%	-99.79%	—	$21
20Y	-99.79%	-26.59%	-99.79%	—	$21
30Y	-99.79%	-18.63%	-99.79%	—	$21

Risk & Highlights

Best Year+258.12%2020

Worst Year-95.75%2018

Max Drawdown-39.34%2026-03-13 → 2026-05-06

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	+31.88%	+31.88%	—	+0.41%	+31.5pp
2025	+50.00%	+50.00%	—	+16.64%	+33.4pp
2024	+22.41%	+22.41%	—	+24.00%	-1.6pp
2023	-54.00%	-54.00%	—	+24.81%	-78.8pp
2022	-72.46%	-72.46%	—	-19.95%	-52.5pp

OCGN outperformed the S&P 500 by 72.12pp over the past year (+103.44% vs +31.32%).

Loading summary...

OCGN Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
OCGNOcugen, Inc.	$493M	-17.8%	+5.4%	+103.4%	—	+102.6%	-84.8%	-98.5%
REPLReplimune Group, Inc.	$272M	-60.0%	-61.6%	-54.4%	—	-81.1%	-90.4%	-77.4%
EDITEditas Medicine, Inc.	$311M	+16.7%	+54.9%	+138.7%	—	-67.0%	-90.8%	-89.5%
BEAMBeam Therapeutics Inc.	$3.3B	+33.4%	+19.1%	+102.2%	—	-3.0%	-53.9%	+72.4%
NTLAIntellia Therapeutics, Inc.	$1.6B	+4.1%	+50.4%	+91.0%	—	-67.9%	-79.2%	-37.3%
CRSPCRISPR Therapeutics AG	$5.3B	+12.1%	+2.4%	+66.1%	—	-1.6%	-48.9%	+290.9%
RCKTRocket Pharmaceuticals, Inc.	$418M	+11.6%	+11.6%	-38.8%	—	-81.9%	-91.1%	-90.7%
ADVMAdverum Biotechnologies, Inc.	$96M	—	—	+35.0%	—	-46.5%	-88.2%	-89.5%
BOLDBoundless Bio, Inc.	$35M	+33.9%	+29.5%	-1.9%	—	—	—	—
JANXJanux Therapeutics, Inc.	$883M	-2.1%	+7.1%	-42.8%	—	+6.6%	-41.9%	-41.9%
REGNRegeneron Pharmaceuticals, Inc.	$74.9B	-5.5%	-7.0%	+29.7%	+0.6pp	-3.6%	+45.4%	+96.0%

Compare:OCGN vs REPL OCGN vs EDIT OCGN vs BEAM OCGN vs REPL vs EDIT

About OCGN Dividend Returns

Ocugen, Inc. (OCGN) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of OCGN over the past year?

Ocugen, Inc. (OCGN) delivered a return of 103.44% over the past year. Since OCGN does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in OCGN be worth today?

A $10,000 investment in Ocugen, Inc. one year ago would be worth $20,344 today, representing a gain of $10,344.

Q3Does OCGN pay dividends?

Ocugen, Inc. (OCGN) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For OCGN, the total return equals the price-only return.

Q4Did OCGN beat the S&P 500?

Yes, Ocugen, Inc. (OCGN) outperformed the S&P 500 by 72.12 percentage points over the past year. OCGN delivered a total return of 103.44%, compared to the S&P 500's 31.32%. This 72.12pp alpha means investors in OCGN earned more than a passive S&P 500 index fund.

Q5What is OCGN's worst drawdown?

Ocugen, Inc. (OCGN) experienced a maximum drawdown of -39.34% over the past year, declining from its peak on 2026-03-13 to its trough on 2026-05-06. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is OCGN's long-term total return over 10, 20, or 30 years?

Here are Ocugen, Inc. (OCGN)'s long-term returns with dividends reinvested. Over 10 years, the total return is -98.5% (-34.4% CAGR) — $10,000 would have grown to $147. Over 20 years: -99.8% total return (-26.6% CAGR) — $10,000 → $21. Over 30 years: -99.8% total return (-18.6% CAGR) — $10,000 → $21. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was OCGN's best and worst year?

Ocugen, Inc.'s best calendar year was 2020 with a total return of 258.1%. Its worst year was 2018 with a total return of -95.7%. This range shows the volatility investors should expect — the difference between the best and worst year is 353.9 percentage points.